A double-blind randomized controlled trial comparing 3mg and 1mg of ranisetron for the control of chemotherapy-induced acute emesis

ABSTRACT: Interventions: Granisetron 3mg + dexamethasone (drip infusion) Granisetron 1mg + dexamethasone (drip infusion) Primary outcome(s): complete protection from vomiting within 24 hours Study Design: Parallel Randomized

DISEASE(S): Malignant Tumor (breast Cancer, Lung Cancer, Gastric Cancer, Esophagus Cancer, Colorectal Cancer, Etc)

PROVIDER: 2616484 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR